Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Top Cited Papers
Open Access
- 14 March 2004
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 36 (4) , 417-422
- https://doi.org/10.1038/ng1330
Abstract
Aberrant WNT pathway signaling is an early progression event in 90% of colorectal cancers1. It occurs through mutations mainly of APC and less often of CTNNB1 (encoding β-catenin)1,2,3 or AXIN2 (encoding axin-2, also known as conductin)4. These mutations allow ligand-independent WNT signaling that culminates in abnormal accumulation of free β-catenin in the nucleus1,2,3. We previously identified frequent promoter hypermethylation and gene silencing of the genes encoding secreted frizzled-related proteins (SFRPs) in colorectal cancer5. SFRPs possess a domain similar to one in the WNT-receptor frizzled proteins and can inhibit WNT receptor binding to downregulate pathway signaling during development6,7,8,9,10. Here we show that restoration of SFRP function in colorectal cancer cells attenuates WNT signaling even in the presence of downstream mutations. We also show that the epigenetic loss of SFRP function occurs early in colorectal cancer progression and may thus provide constitutive WNT signaling that is required to complement downstream mutations in the evolution of colorectal cancer.Keywords
This publication has 28 references indexed in Scilit:
- Requirement for a Nuclear Function of β-Catenin in Wnt SignalingMolecular and Cellular Biology, 2003
- Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomasOncogene, 2002
- Secreted Frizzled‐related proteins: searching for relationships and patternsBioEssays, 2002
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancerNature Genetics, 2001
- Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signallingNature Genetics, 2000
- Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3βScience, 1998
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997